美國政治

US democracy is still in the danger zone

Threat has outgrown Trump as Republican states seek to control what happens in future elections

Early into Donald Trump’s presidency, the Economist Intelligence Unit downgraded the US to a “flawed democracy”. Unfortunately it still belongs there. Far from putting Trumpian distempers into the rear-view mirror, Joe Biden’s victory has deepened them. Trump’s style of politics has taken on a life independent of him. Even if he retired to a monastery, the Republican party has chosen its course. 

The danger this poses to US democracy is twofold. The first is to America’s rules of choosing its president. The grip of what is rightly called the “big lie” about last year’s “stolen election” should not be underestimated. Had there been any evidence of fraud last November, William Barr, Trump’s ultraloyal attorney-general, would have jumped on it. His justice department found no evidence of malpractice.

Like all myths, the stolen election is immune to evidence. Nor can it be dismissed, as it sometimes is, as purely the result of sore loser syndrome. Republican-governed states such as Arizona and Georgia are passing laws to seize control over their electoral college returns. They are motivated as much by what they want to happen in 2024 as by an effort to placate Trump. These are forward-looking power grabs from independent election officials. Some such provisions would embarrass Viktor Orban’s Hungary — the original “illiberal democracy”. The pattern is to deprive Democratic cities such as Houston of voting outlets while making it easier to vote in conservative rural areas. 

您已閱讀34%(1491字),剩餘66%(2899字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。

中東期待沙烏地阿拉伯制衡川普

阿拉伯國家希望穆罕默德王儲和美國當選總統川普的密切關係能夠緩和川普政府的中東政策。

投資者押注防務支出增加,Palantir成爲「川普交易」贏家之一

彼得•蒂爾創立的數據公司的最大客戶是美國政府,自川普本月當選以來,其市值增加了230億美元。

Lex專欄:成長來之不易,雀巢前景平淡

要實現其成長目標,這家瑞士集團需要增加行銷投資。

Lex專欄:便宜商品是沃爾瑪股價上漲的基礎

沃爾瑪通過吸引高收入顧客和增加其他收入來源,出色地應對了經濟不景氣和通膨帶來的挑戰。

Lex專欄:奢侈品品牌寄希望於自己的美國夢

奢侈品在美國越來越具有吸引力,可能爲該行業提供新的成長跑道。

諾和諾德準備下一代減肥藥的試驗結果

這家丹麥公司預計,最新數據將顯示CagriSema可在一年多的時間內減輕25%的體重。
設置字型大小×
最小
較小
默認
較大
最大
分享×